Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2026 08:30 ET | Source: SNS Insider pvt ltd

Competent Cells Market Size to Reach USD 7.06 Billion by 2035, Driven by Synthetic Biology Expansion and Advanced Gene Editing Workflows – SNS Insider

Austin, United States, March 25, 2026 (GLOBE NEWSWIRE) -- Competent Cells Market Size & Growth Analysis: According to SNS Insider, The Component Cells Market size is valued at USD 2.58 Billion...
March 25, 2026 08:05 ET | Source: Imunon, Inc.

IMUNON Reports Updated Phase 2 Data Showing Continued Improvement in Median Overall Survival with IMNN-001 in Women with Newly Diagnosed Advanced Ovarian Cancer

The increase in median overall survival among women treated with IMNN-001 in the OVATION 2 trial rose from the previously reported 11.1 months to 14.7 months following final data analysis Patients...
March 25, 2026 07:00 ET | Source: Beam Therapeutics

Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development

Treatment with 60 mg of BEAM-302 Led to Mean Steady-state Total AAT Level of 16.1 µM and All Patients Consistently and Durably Above the 11 µM Protective AAT Threshold with up to 12 Months of...
March 24, 2026 16:05 ET | Source: BioCardia, Inc.

BioCardia Reports 2025 Business Highlights and Financial Results

SUNNYVALE, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
March 24, 2026 15:53 ET | Source: Pomerantz LLP

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) and...
March 24, 2026 08:37 ET | Source: Yacht Club de Monaco

Scientists and explorers unite at the Yacht Club de Monaco for 'A Day of Exploration'

MONACO, March 24, 2026 (GLOBE NEWSWIRE) -- From the preservation of ocean species to exploration on the Moon, from the study of underwater shipwrecks off the coast of Majorca to the oceans in space....
March 24, 2026 08:35 ET | Source: Waldencast plc

Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD)...
March 24, 2026 08:00 ET | Source: Leapfrog Bio

Leapfrog Bio Appoints Alan Ashworth, Ph.D., FRS, to Chair Company’s Scientific Advisory Board

-- Dr. Ashworth Brings Decades of Scientific and Clinical Experience Translating Synthetic Lethality Discoveries into Precision Cancer Therapies -- SOUTH SAN FRANCISCO, Calif., March 24, 2026 ...
March 24, 2026 08:00 ET | Source: Applied Stemcell

Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development

Applied StemCell and Cellipont collaborate to enable seamless iPSC cell therapy development from early engineering to GMP production and scale-up.
March 24, 2026 08:00 ET | Source: Imunon, Inc.

IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026

LAWRENCEVILLE, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the...